ASN's Mission

ASN leads the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on Twitter

Kidney Week

Abstract: FR-PO370

Regulation and Role of NADPH Oxidase 4 in CKD

Session Information

  • CKD: Mechanisms - II
    November 08, 2019 | Location: Exhibit Hall, Walter E. Washington Convention Center
    Abstract Time: 10:00 AM - 12:00 PM

Category: CKD (Non-Dialysis)

  • 2103 CKD (Non-Dialysis): Mechanisms


  • De Seigneux, Sophie M., University of Geneva, Geneva, Switzerland
  • Rajaram, Renuga Devi, University of Geneva, Geneva, Switzerland
  • Faivre, Anna, University of Geneva, Geneva, Switzerland
  • Delitsikou, Vasiliki, University of Geneva, Geneva, Switzerland
  • Jaquet, Vincent, University of Geneva, Geneva, Switzerland
  • Lindenmeyer, Maja, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
  • Cohen, Clemens D., Klinikum Munchen, Munchen, Germany

While low-levels of reactive oxygen species (ROS) are important for physiological signaling, excessive ROS production has been implicated in CKD progression. Therefore, understanding the contribution of renal redox signaling in physiological and pathological context is essential to develop new therapeutics. NADPH oxidase 4 (NOX4) catalyzes the formation of hydrogen peroxide (H2O2). NOX4 is highly expressed in the kidney, but its role in renal damage is unclear and may depend on its specific tissue localization.


We performed immunostaining with a specific anti-NOX4 antibody and measured NOX4 mRNA expression in human renal biopsies encompassing diverse renal diseases. We generated transgenic mice specifically overexpressing mouse Nox4 in renal tubular cells and subjected the animals to acute and chronic unilateral ureteral obstruction (UUO) model of fibrosis.


In normal human kidney, NOX4 protein expression was at its highest on the basolateral side of proximal tubular cells. NOX4 expression increased in mesangial cells and podocytes in diabetic nephropathy. In tubular cells, NOX4 protein expression decreased in all types of chronic renal disease studied. This finding was substantiated by decreased NOX4 mRNA expression in the tubulo-interstitial compartment in a repository of 176 human renal biopsies. Overexpression of tubular NOX4 in mice resulted in enhanced renal production of H2O2, increased NRF2 protein expression and decreased glomerular filtration, likely via stimulation of the tubulo-glomerular feedback. Tubular NOX4 overexpression had no obvious impact on kidney morphology, apoptosis, or fibrosis at baseline. Under acute and chronic tubular injury induced by UUO, overexpression of NOX4 in tubular cells did not modify the course of the disease.


NOX4 expression was decreased in tubular cells in all types of CKD tested. Tubular NOX4 overexpression did not induce injury in the kidney, and neither modified microvascularization, nor kidney structural lesions in fibrosis.